arrow
N

Neeha Zaidi

Johns Hopkins University
H指数:27
被引数:3,581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial

携带KRAS突变肽疫苗及双重检查点封锁的转移性结直肠癌:一项I期临床试验

2026-06-230
OAAI
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

Publisher Correction: 突变KRAS疫苗联合双重免疫检查点阻断在切除的胰腺癌中的I期临床试验

2026-04-150
OAAI
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

携带双检查点阻断的突变KRAS疫苗在切除的胰腺癌中的应用:一项I期临床试验

2026-02-100
OAAI
Comparative assessment of physiochemical metrics for the clustering of adaptive immune receptor repertoires

适应性免疫受体库聚类中物理化学指标的对比评估

2025-11-260
OAAI
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

一种纤维层状肝细胞癌的治疗性多肽疫苗:一项1期临床试验

2025-11-240
OAAI
Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories

人类可解释的语法对多细胞系统生物学模型进行编码,以实现虚拟细胞实验室的民主化。

Cell
IF42.5
2025-07-260
OAAI
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
2024-10-251
PRE
An analysis of outcomes in patients (pts) with advanced pancreatic cancer (PDAC) whose tumors harbor pathogenic BRCA1 or BRCA2 mutations based on gene mutation location
2024-09-150
PRE
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration
2024-08-012
PRE
Identification of a novel morphology of tertiary lymphoid structure in patients with hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade
2024-03-220
PRE
A differential ligand- receptor network inference method to identify alterations in communication between myeloid cells and CD8 T cells in response to PancVAX neo-epitope peptide vaccine, anti-CTLA-4 and anti-PD-1 antibodies in a murine model of pancreatic ductal adenocarcinoma
2024-03-220
PRE
Spatial proteomics and transcriptomics reveal early immune cell organization in human pancreatic intraepithelial neoplasia
2024-01-160
PRE
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy
2023-12-087
OA